Aldenkamp AP, Alpherts WC. (2006) The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 47:1153-1159.
Aldenkamp AP, Alpherts WC, Blennow G, Elmqvist D, Heijbel J, Nilsson HL, Sandstedt P, Tonnby B, Wahlander L, Wosse E. (1993) Withdrawal of antiepileptic medication in children–effects on cognitive function: The Multicenter Holmfrid Study. Neurology 43:41-50.
Aldenkamp AP, Alpherts WC, Diepman L, van ‘t Slot B, Overweg J, Vermeulen J. (1994) Cognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsy. Epilepsy Res 19:37-43.
Aldenkamp AP, Arends J, Bootsma HP, Diepman L, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Vocht J. (2002a) Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 43:19-26.
Aldenkamp, AP, Baker, G, Pieters, MS, Schoemaker, HC, Cohen, AF, Schwabe, S. (1995). The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity. Epilepsy Res 20:229-239.Aldenkamp AP, Mulder OG, Overweg J. Cognitive Effects of Lamotrigine as First-line Add-on in Patients with Localization-related (Partial) Epilepsy. J Epil 1997;10:117-121.
Aldenkamp AP, van Meel HF, Baker GA, Brooks J, Hendriks MP. (2002b) The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests. Seizure 11:231-237.
Boelen S, Nieuwenhuis S, Steenbeek L, Veldwijk H, van de Ven-Verest M, Tan IY, Aldenkamp AP. (2005) Effect of epilepsy on psychomotor function in children with uncomplicated epilepsy. Dev Med Child Neurol 47:546-550.
Braakman HM, Ijff DM, Vaessen MJ, Debeij-van Hall MH, Hofman PA, Backes WH, Vles JS, Aldenkamp AP. (2012) Cognitive and behavioural findings in children with frontal lobe epilepsy. Eur J Paediatr Neurol 16(6):707-15.
Breuer LEM, Grevers E, Boon P, Bernas A, Bergmans JWM, Besseling RMH, Klooster DCW, de Louw A, Mestrom RMC, Vonck K, Zinger S, Aldenkamp AP. (2016) Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica to be published.
Deckers CL, Hekster YA, Keyser A, van Lier HJ, Meinardi H, Renier WO. (2001) Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia 42:1387-1394.
Donati F, Gobbi G, Campistol J, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 2007;16:670-679.
Grevers E, Breuer LE, IJff DM, Aldenkamp A P (2015). Mental slowing in relation to epilepsy and antiepileptic medication. Acta Neurol Scand 134:116-22.
Helmstaedter C, Witt J. Assessing cognitive antiepileptic drug effects in the individual patient. In: Helmstaedter C, Hermann B, Lassonde M, Kahane P, Arzimanoglou A, eds. Neuropsychology in the care of people with epilepsy: John Libbey Eurotext, 2011: 170.
IJff DM, Aldenkamp AP. Cognitive side-effects of antiepileptic drugs in children. (2013)Handb Clin Neurol 111:707-718.
IJff DM, van Veenendaal TM, Debeij-van Hall MH, Jansen JF, de Louw AJ, Majoie MH, Aldenkamp AP. (2016) The Cognitive Profile of Ethosuximide in Children. Paediatr Drugs 18(5):379-85.
IJff DM, van Veenendaal TM, Majoie HJ, de Louw AJ, Jansen JF, Aldenkamp AP. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy. Acta Neurol Scand 2015;131:347-354.
La Noce A. (2010) Evaluating the Cognitive Effects of Antiepileptic Treatment in Children with Epilepsy. J Clin Stud 2010:30-34.
Lemstra AW, Kuiper RB, Schmand B, van Gool WA.(2008) Identification of responders to rivastigmine: a prospective cohort study. Dement Geriatr Cogn Disord 25:60-6.
Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. (2003) Differential cognitive and behavioral effects of topiramate and valproate. Neurology 60:1483-1488.
Monti M, Salerno GG, Montanari M, et al. (2011) Gli effetti cognitivi del levetiracetam in età evolutiva. Boll Lega It Epil 142:173-175.
Nicolai J, Aldenkamp AP, Huizenga JR, Teune LK, Brouwer OF. (2007) Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy. J Clin Psychopharmacol 27:221-224.
Ogunrin O, Adamolekun B, Ogunniyi AO. (2005) Cognitive effects of anti-epileptic drugs in Nigerians with epilepsy. African Journal of Neurological Sciences 24.
Posar A, Salerno GG, Monti M, Santucci M, Scaduto MC, Parmeggiani A. (2014) Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy. 9:115-120.
Pressler RM, Binnie CD, Coleshill SG, Chorley GA, Robinson RO. (2006) Effect of lamotrigine on cognition in children with epilepsy. Neurology 66:1495-1499.
Scott Werry, J., & Aman, M. G. (1999). Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. In: Plenum Publishing Corporation.
Sundqvist A, Tomson T, Lundkvist B. (1998) Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study. Ther Drug Monit 20:149-157.
van Veenendaal TM, IJff DM, Aldenkamp AP, Lazeron RH, Puts NA, Edden RA, Hofman PA, de Louw AJ, Backes WH, Jansen JF. (2016) Glutamate concentrations vary with antiepileptic drug use and mental slowing. Epilepsy Behav 64(Pt A):200-205.
van Veenendaal TM, IJff DM, Aldenkamp AP, Lazeron RH, Hofman PA, de Louw AJ, Backes WH, Jansen JF. (2017) Chronic antiepileptic drug use and functional network efficiency: A functional magnetic resonance imaging study. World J Radiol 9:287-294.
Epilepsy
Aldenkamp AP, Arends J, Overweg-Plandsoen TC, van Bronswijk KC, Schyns-Soeterboek A, Linden I, Diepman L. (2001) Acute cognitive effects of nonconvulsive difficult-to-detect epileptic seizures and epileptiform electroencephalographic discharges. J Child Neurol 16:119-123.
Arinzechi EO, Ogunrin OA, Nwosu CM, Nwani PO, Enwereji KO, Asomugha LA, Dimkpa U. (2016) A community-based case-control study of prevalence and pattern of cognitive impairments in patients with epilepsy residing in South-Eastern Nigeria. J Neurosci Rural Pract 7:405-11.
Arinzechi EO, Ogunrin OA, Nwosu CM, Nwani PO, Enwereji KO, Asomugha LA, Dimkpa U. (2019) Seizure frequency and risk of cognitive impairment in people living with epilepsy in a sub-urban community in South Eastern Nigeria J Clin Neurosc 59:98-105.
De Kinderen DJA, Lambrechts DAJE, Postulart D, Kessels AGH, Hendriksen JGM, Aldenkamp AP, Evers SMAA, Majoie MHJM. (2011) Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurology 11:10.
Didden R, de Moor JM, Korzilius H. (2009) Sleepiness, on-task behavior and attention in children with epilepsy who visited a school for special education: a comparative study. Res Dev Disabil 30:1428-1434.
Espie CA, Kerr M, Paul A, O’Brien G, Betts T, Clark J, Jacoby A, Baker G. (1997) Learning disability and epilepsy. 2, a review of available outcome measures and position statement on development priorities. Seizure 6:337-350.
Fonseca Wald, ELA, S. Klinkenberg, et al. (2019) Cognitive development in absence epilepsy during long-term follow-up. Child Neuropsychol 25(8):1003-1021.
IJff DM, Postulart D, Lambrechts DA, Majoie MH, de Kinderen RJ, Hendriksen JG, Evers SM, Aldenkamp AP. (2016) Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav 60:153-7.
Jehle, L. (2014) The Development of Cognitive and Behavioral Deficits in Rolandic Epilepsy: Patients newly diagnosed with Rolandic epilepsy compared to patients in a later stage of the syndrome. Master Thesis, Amsterdam, 2014.
Odiase FE. (2005) The correlation of CD4 count and cognitive function in HIV/AIDS. A case control study in University of Benin Teaching Hospital. Dissertation, Benin, 2005.
Ogunrin O, Adamolekun B, Ogunniyi AO, Aldenkamp AP. (2000) Cognitive function in Nigerians with newly diagnosed epilepsy. Can J Neurol Sci 27:148-151.
Preiss M, Shatil E, Cermakova R, Cimermanova D, Ram I. (2013) Personalized cognitive training in unipolar and bipolar disorder: a study of cognitive functioning. Front. Hum. Neurosci. 7:108. Epub 2013/05/30.
Sunmonu TA, Ogunrin O, Komolafe MA, Ogunniyi A. (2008) Seizure Variables And Cognitive Performance In Patients With Epilepsy. African Journal of Neurological Sciences 27.
Taylor J, Kolamunnage-Dona R, Marson AG, Smith PE, Aldenkamp AP, Baker GA (2010) Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? Epilepsia 51:48-56.
Titomanlio L, Romano A, Romagnuolo G, Del Giudice E. (2003) Subtle neuropsychological alterations in children with rolandic epilepsy. Ital J Pediatr 29:276-280.
Tromp SC, Weber JW, Aldenkamp AP, Arends J, vander Linden I, Diepman L. (2003) Relative influence of epileptic seizures and of epilepsy syndrome on cognitive function. J Child Neurol 18:407-412.
Van Tuijl JH, Van Raak EPN, De Krom MCTFM, Lodder J, Aldenkamp AP. (2011) Early treatment after stroke for the prevention of late epileptic seizures: A report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. Seizure 20:285-291.
van den Berg L, de Weerd A, et al. (2019) Working memory in pediatric frontal lobe epilepsy. Applied Neuropsychology: Child DOI:10.1080/21622965.2019.1611431
van den Berg L, de Weerd A, et al. (2020) Cognitive control deficits in pediatric frontal lobe epilepsy. Epilepsy Behav 102 DOI:10.1016/j.yebeh.2019.106645
Vlooswijk MC, Jansen JF, Reijs RP, de Krom MC, Kooi ME, Majoie HJ, Hofman PA, Backes WH, Aldenkamp AP (2008) Cognitive fMRI and neuropsychological assessment in patients with secondarily generalized seizures. Clin Neurol Neurosurg 110:441-450.
Witt JA, Helmstaedter C (2009) Neuropsychology in epilepsy part II: towards an establishment of diagnostic guidelines. Fortschr Neurol Psychiatr 77:691-698.
Recreational Drugs
Reneman L, et al. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacol, 2006. 20(3): p. 389-99.
Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health technology assessment 2009;13:iii-iv, ix-xii, 1-315.
Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. (2006) Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol 98:86-96.
Toxic Syndromes
Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB (2016) Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes. Brain Imag Behav 10:437-444.
EEG
Aldenkamp AP, Arends J. (2004) The relative influence of epileptic EEG discharges, short nonconvulsive seizures, and type of epilepsy on cognitive function. Epilepsia 45:54-63.
Aldenkamp AP, Arends J. (2004) Effects of epileptiform EEG discharges on cognitive function: Is the concept of “transient cognitive impairment” still valid? Epilepsy Behav 5 Suppl 1: 25-34.
Aldenkamp AP, Arends J, de la Parra NM, Migchelbrink EJ (2010) The cognitive impact of epileptiform EEG discharges and short epileptic seizures: relationship to characteristics of the cognitive tasks. Epilepsy Behav 17:205-209.
Aldenkamp AP, Arends J, Verspeek S, Berting M. (2004) The cognitive impact of epileptiform EEG-discharges; relationship with type of cognitive task. Child Neuropsychol 10:297-305.
Aldenkamp AP, Beitler J, Arends J, van der Linden I, Diepman L. (2005) Acute effects of subclinical epileptiform EEG discharges on cognitive activation. Funct Neurol 20:23-28.
Domizio S, Conte E, Puglielli C, Domizio R, Verrotti A, Pollice R, Casacchia M, Conti CM, Roncone R, Sabatino G, Doyle R, Barbacane RC, Conti P. (2008) Epileptic EEG discharges and short non-convulsive crisis: Influence on cognitive and psychobehavioural functions in youths. Clin Invest Med 31:E20-40.
Ebus SC, IJff DM, den Boer JT, van Hall MJ, Klinkenberg S, van der Does A, Boon PJ, Arends JB, Aldenkamp AP. (2015) Changes in the frequency of benign focal spikes accompany changes in central information processing speed: a prospective 2-year follow-up study. Epilepsy Behav 43:8-15.
Nicolai J, Ebus S, Biemans DP, et al. The cognitive effects of interictal epileptiform EEG discharges and short nonconvulsive epileptic seizures. Epilepsia 2012;53:1051-1059.
Neurosurgery
Alpherts WCJ, Aldenkamp AP, Van Veelen CWM. Computerized Testing during Operation under local Anesthesia. Epilepsia 1997;38 Suppl. 3:236 (abstract).
Alpherts WCJ, Vermeulen J, Hendriks MP, Franken ML, van Rijen PC, Lopes da Silva FH, van Veelen CWM. (2004) Long-term effects of temporal lobectomy on intelligence. Neurology 62:607-611.
Alpherts WCJ, Vermeulen J, van Rijen PC, Lopes da Silva FH, van Veelen CWM. (2006) Verbal memory decline after temporal epilepsy surgery? A 6-year multiple assessments follow-up. Neurology 76:626-631.
Alpherts WCJ, Vermeulen J, van Veelen CW. (2000) The Wada test: prediction of focus lateralization by asymmetric and symmetric recall. Epilepsy Res 39:239-249.
Cancer
Andreotti C, Root JC, Schagen SB, et al. (2016) Reliable change in neuropsychological assessment of breast cancer survivors. Psychooncology 25:43-50.
Bial AK, Schilsky RL, Sachs GA. (2006) Evaluation of cognition in cancer patients: special focus on the elderly. Crit Rev Oncol Hematol 60:242-255.
De Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FSAM, Nederveen AJ, Boven E, Schagen SB. (2010) Cerebral Hyporesponsiveness and Cognitive Impairment 10 Years After Chemotherapy for Breast Cancer. Hum Brain Mapp 32:1206-1219.
Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59:60-70.
Hess L, Chin S. Changes in cognitive function related to chemotherapy. In: Alberts D, Lluria-Prevatt M, Kha S, Weihs K, eds. Supportive Cancer Care: Springer, 2016: 183-206.
Horowitz T. (2013) Does chemotherapy lead to a visual search deficit? Perception & Psychophysics 42 ECVP Abstract Suppl. :214.
Hulshof MC, Stark NM, van der Kleij A, Sminia P, Smeding HM, Gonzalez Gonzalez D. (2002) Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain. Strahlenther Onkol 178:192-198.
Jansen CE, Miaskowski C, Dodd M, Dowling G. (2005) Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature. Oncol Nurs Forum 32:329-342.
Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA. (2007) A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 34:997-1005.
Mandelblatt J, Armetta C, Yabroff KR, Liang W, Lawrence W. (2004) Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr: 8-44.
Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. (2005) Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients–evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 12:279-287.
Menning S, de Ruiter MB, Veltman DJ, et al. (2017) Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain imaging and behavior
Ono M, Ogilvie JM, Wilson JS, et al. (2015) A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Frontiers in oncology 2015;5:59.
Peterson R, Noggle C, Shahani L, Dean R. Residuals in post-chemotherapy, non-depressed patients with leukemia that is in remission. Neuropsychological Trends 2016;19:35-43.
Pullens MJJ. (2013) Unraveling the ‘chemobrain’: A prospective study in patients with breast cancer.DissertationRaffa RB, Duong PV, Finney J, Garber DA, Lam LM, Mathew SS, Patel NN, Plaskett KC, Shah M, Jen Weng HF. (2006) Is ‘chemo-fog’/’chemo-brain’ caused by cancer chemotherapy? J Clin Pharm Ther 31:129-138.
Raffa RB, Tallarida RJ. (2010) Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced ‘chemo-fog’. J Clin Pharm Ther 35:249-255
Rubio R, Sirgo A, Forcadell E, Mele M, Guma J (2009) Deterioro cognitivo inducido por los tratamientos oncológicos sistémicos en el cáncer de mama no metastático: revisión de estudios. Psicooncología 6:83-120.
Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S, van Dam FS. (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387-1397.
Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650.
Schilder C, Seynaeve C, Boogerd W, Beex L, van de Velde C, Nortier J, Gundy C, Huizenga H, Linn S, van Dam F, Schagen S. (2009) Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal breast cancer patients: results from the Dutch TEAM trial.
Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, Van Dam FS, Schagen SB. (2008) Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol :1-10.
Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. (2006) A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 20:76-89.
van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S. (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218.
Parkinson
Vingerhoets G, van der Linden C, Lannoo E, Vandewalle V, Caemaert J, Wolters M, Van den Abbeele D. (1999) Cognitive outcome after unilateral pallidal stimulation in Parkinson’s disease. J Neurol Neurosurg Psychiatry 66:297-304.
HIV/AIDS
Obiabo YO, Ogunrin OA, Ogun AS. (2012) Effects of highly active antiretroviral therapy on cognitive functions in severely immune-compromised HIV-seropositive patients. J Neurol Sc 313:115-122.
Odiase FE, Ogunrin OA, Ogunniyi AA. (2007) Memory performance in HIV/AIDS–a prospective case control study. Can J Neurol Sci 34:154-159.
Ogunrin O, Odiase FE. (2007) Predictive validity and usefulness of visual scanning task in HIV/AIDS – a case control African Journal of Neurological Sciences 26:45-52.
Sunmonu TA, O AO, Imarhiagbe FA, Owolabi LF, Komolafe MA, Llesanmi OS. (2016) Cognitive function in patients with newly diagnosed HIV infection in a tertiary health facility in south – west Nigeria: Assessment using computer-assisted neuropsychological test battery. eNeurologicalSci 3:54-9. Epub 2016/02/24.
Sunmonu TA, Sellner J, Ogunrin OA, Imarhiagbe FA, Komolafe MA, Afolabi OT, Ilesanmi OSOlanrewaju F, Oladimeji BY. (2015) Intellectual Impairment in Patients with Newly Diagnosed HIV Infection in Southwestern Nigeria. BioMed Research International Article ID 185891.
Wilson S, Milanini B, Javandel S, Nyamayaro P, Valcour V. (2021) Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review. Curr. HIV/AIDS rep. 18(6):581-92. Epub 2021/11/26.
Other Diseases
Blackwell JE, Alammar HA, Weighall AR, Kellar I, Nash HM. A systematic review of cognitive function and psychosocial well-being in school-age children with narcolepsy. Sleep Med Rev 2017 34:82-93
Egbi O, Ogunrin O, Oviasu E. Cognitive deficits of patients with chronic kidney disease and effect of hemodialysis. Greener Journal of Medical Sciences 2015;5:19-25
Gschwandtner U, Pfluger M, Aston J, Borgwardt S, Drewe M, Stieglitz RD, Riecher-Rossler A. (2006) Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:201-206.
Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B (2007) Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 78:1092-1096.
Knauf JK. Untersuchungen nach Stentangioplastie und Thrombendarteriektomie einer extrakraniellen Stenose der Arteria carotis interna und Veränderungen kognitiver Funktionen. Dissertation, Göttingen 2011.
Kulistak P. Kognitivni Deficit u Traumatickeho Poskozeni Mozku. In: Preiss M, Kucerova H, eds. Neuropsychologie v Neurologii: Grada Publishing, 2011: 110-113.
Moniz, EMF. (2015) Défices cognitivos em pacientes com depressão unipolar: Influência das variáveis idade, género e história anterior de tentativas de suicídio. Dissertation.
Ogunrin AO, Unuigbe EI, Azubuike C. (2006) Memory and perceptuo-motor performance in Nigerians with chronic renal impairment. Med Sci Monit 12:CR535-539.
Owolabi LF, Adbu A, Ibrahim A, Owolabi DS, Nalado A, Bappa A, Taura AA. (2016) Cognitive function assessment in patients with end-stage renal disease in Nigeria: A single center experience. Ann Afr Med 15(3):138-44.
Owolabi LF, Abdu A, Ibrahim A, Owolabi DS, Nalado A, Bappa A, et al. 2016 Related Factors and Predictors of Cognitive Dysfunction in Chronic Kidney Disease on Maintenance Hemodialysis in Nigeria. J Neurosc Rur Pract 7(Suppl 1):S62-S7. Epub 2017/02/07.
Partinen M, Hirvonen K, Hublin C, Halavaara M, Hiltunen H. (2003) Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med 4:553-561.
Riva D, Aggio F, Vago C, Nichelli F, Andreucci E, Paruta N, D’Arrigo S, Pantaleoni C, Bulgheroni S. (2006) Cognitive and behavioural effects of migraine in childhood and adolescence. Cephalalgia 26:596-603.
Sienaert P, Janssens J. Gevalsbeschrijving: Preseniele dementie en hyperparathyreoïdie. Tijdschrift voor Psychiatrie 1998;40:40-46.
Stroobant N, Van Nooten G, Van Belleghem Y, Vingerhoets G. (2005) Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on- and off-pump coronary artery bypass grafting. Chest 127:1967-1976.
Sunmonu TA, Adekanle O, Komolafe MA, Ndububa DA. (2012) Cognitive function in patients with liver cirrhosis without overt hepatic encephalopathy: assessment using an automated neuropsychological test battery.Arab J Gastroenterol 13(1):4-8.
Sunmonu TA, Adeniyi BO, Oyegunle T, Ogunrin OA, Erhabor GE. (2019) Cognitive Functions in Patients with Clinically Stable (Mild to Moderate) Asthma in South West Nigeria: Assessment using Automated Neuropsychological Test Battery. West Afr J Med36(2): 158-164.
van Andel E, Maassen B, Eling P. (2004) Executieve functies bij kinderen met spraakmoeilijkheden. Stem-, Spraak- en Taalpathologie 12(2):117-136.van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM. (2002) Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment. J Psychopharmacol 16:337-343.
Van Harten B. (2006) Aspects of Subcortical Ischaemic Vascular Disease. Early clinical manifestations and associations with Type 2 diabetes mellitus. Vrije Universiteit, Amsterdam, p. 116.
Van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. (2007) Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36:164-170.
Vanninen R, Aikia M, Kononen M, Partanen K, Tulla H, Hartikainen P, Paranen J, Manninen H, Enberg P, Hippelainen M. (1998) Subclinical cerebral complications after coronary artery bypass grafting: prospective analysis with magnetic resonance imaging, quantitative electroencephalography, and neuropsychological assessment. Arch Neurol 55:618-627.
Voorthuis A. (2010) Motorproblems and Laterality in a Childpsychiatric Population and the Relation with Language-, and Math Performance.. Dissertation. Leiden, 2010.Williams UE, Owolabi MO, Ogunniyi A, Ezunu EO. (2013) Prevalence and pattern of neurocognitive impairment in nigerians with stages 3 to 5 chronic kidney disease. ISRN neurology 2013:374890
Test Research
Aldenkamp AP, Vermeulen J, Alpherts WCJ, Overweg J, Van Parijs JAP, Verhoeff NPLG. (1991) Validity of computerized testing: patient dysfunction and complaints versus measured changes. In Dodson WE, Kinsbourne M, (eds) Assessment of cognitive function in epilepsy , Demos, New York, pp. 51-68.
Alpherts W. (2009) Corsi’s Blocks revisited. Epilepsia 50:143-144.
Alpherts WCJ, Vermeulen J, Franken ML, Hendriks MP, van Veelen CW, van Rijen PC. (2002) Lateralization of auditory rhythm length in temporal lobe lesions. Brain Cogn 49:114-122.
Bulgheroni S, Nichelli F, Erbetta A, Bagnasco I, Riva D. (2004) Verbal dichotic listening and manual performance in children with congenital unilateral brain lesions. Neuropsychology 18:748-755.
Crowe SF, Benedict T, Enrico J, Mancuso N, Matthews C, Wallace J. (1999) Cognitive determinants of performance on the digit symbol-coding test, and the symbol search test of the wais-iii, and the symbol digit modalities test: An analysis in a healthy sample. Australian Psychologist 34:204 – 210.
Fenwick P, Goldstein LH, Fenwick PBC. (1995) Sensitivity of FePsy Subtests to the Site and Laterality of Epileptic Focus.Epilepsia 36:127.
Goldstein LH, Stubbs P, Pyle P, Fenwick PBC. Can FePsy subtests elicit differences in Performance in patients with unilateral temporal lobe epileptic foci? Epilepsia 1997;38 Suppl. 3:236 (abstract).
Hendriks M, Aldenkamp A, van der Vlugt H. (2000)Neuropsychological assessment of memory functions in epilepsy. In: Schmidt D, Schachter S, eds. Epilepsy – Problem Solving in Clinical Practice. London: Martin Dunitz Ltd, 191-202.
Moerland MC, Aldenkamp AP, Alpherts WCJ. (1988) Computerized Psychological Testing in Epilepsy. In Maarse FJ, Mulder LJM, Sjouw WPB, Akkerman AE, (eds) Computers in Psychology. Methods, Instrumentation and Psychodiagnostics , Swets & Zeitlinger B.V., Amsterdam/Lisse, pp. 157 – 165.
Vander Eyken F (2017) Digitaal ondersteunde neuropsychologische diagnostiek: een beschrijving aan de hand van criteria ter beoordeling van de relevantie van deze neuropsychologische testen. Thesis, Leuven
Witt JA, Alpherts WCJ, Helmstaedter C (2013) Computerized neuropsychological testing in epilepsy: Overview of available tools. Seizure 22:416-23.
Yzebaert C. (2009) De computerized visual searching task als neuropsychologisch instrument voor detectie van aandachtsbias: Een pilootstudie. Dienst Neurologie Laboratorium voor Neuropsychologie Universitair Ziekenhuis Gent, Gent, p. 31.
Rehabilitation
Chamoutová K, Kolár P. Utilization of Neuropsychological Approaches in Rehabilitation. In: Kolár, P., ed. Clinical rehabilitation. Prague: Alena Kobesová, 2013: 344-345.
Ogunrin AO. (2014) Effect of Vinpocetine (Cognitol™) on Cognitive Performances of a Nigerian Population. Ann Med Health Sc Res 4:654-661.
Sport Psychology
De Bock K, Eijnde BO, Ramaekers M, Hespel P. (2004) Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 14:298-307.
Quality of Life
Aldenkamp AP, Blennow G, Sandstedt P, Alpherts WCJ, Elmqvist D, Heijbel J, Nillson HL, Tonnby B, Wählander L, Wosse E. (1994b) Computerized Assessment of Cognitive Function and Quality of Life. In Dodson WE, M.R. T, (eds) Epilepsy and Quality of life in Epilepsy, Raven Press, New York, pp. 199 – 215.
van Tuijl, JH, van Raak, EPM et al. (2019) Cognition and quality of life in patients with poststroke epilepsy: A case–control study. Epilepsy Behav 106444
General
Brodziak A, Kolat E, Rozyk-Myrta A. (2014) In search of memory tests equivalent for experiments on animals and humans. Med Sci Monit 20:2733-2739.
Summala H, Lamble D, Laakso M. (1998) Driving experience and perception of the lead car’s braking when looking at in-car targets. Accid Anal Prev 30:401-407.
van Steveninck AL, Pieters MS, Schoemaker HC, Breimer DD, Cohen AF. (1993) CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers. British Journal of Clinical Pharmacology 35:114-120.
Vingerhoets G, Stroobant N. (1999) Lateralization of cerebral blood flow velocity changes during cognitive tasks. A simultaneous bilateral transcranial Doppler study. Stroke 30:2152-2158.
